1. Home
  2. MRUS vs LUMN Comparison

MRUS vs LUMN Comparison

Compare MRUS & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • LUMN
  • Stock Information
  • Founded
  • MRUS 2003
  • LUMN 1968
  • Country
  • MRUS Netherlands
  • LUMN United States
  • Employees
  • MRUS N/A
  • LUMN N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • LUMN Telecommunications Equipment
  • Sector
  • MRUS Health Care
  • LUMN Telecommunications
  • Exchange
  • MRUS Nasdaq
  • LUMN Nasdaq
  • Market Cap
  • MRUS 5.1B
  • LUMN 5.1B
  • IPO Year
  • MRUS 2016
  • LUMN 1972
  • Fundamental
  • Price
  • MRUS $94.81
  • LUMN $11.00
  • Analyst Decision
  • MRUS Buy
  • LUMN Buy
  • Analyst Count
  • MRUS 18
  • LUMN 7
  • Target Price
  • MRUS $93.72
  • LUMN $5.34
  • AVG Volume (30 Days)
  • MRUS 2.6M
  • LUMN 18.8M
  • Earning Date
  • MRUS 10-31-2025
  • LUMN 10-30-2025
  • Dividend Yield
  • MRUS N/A
  • LUMN N/A
  • EPS Growth
  • MRUS N/A
  • LUMN N/A
  • EPS
  • MRUS N/A
  • LUMN N/A
  • Revenue
  • MRUS $56,228,000.00
  • LUMN $12,824,000,000.00
  • Revenue This Year
  • MRUS $51.77
  • LUMN N/A
  • Revenue Next Year
  • MRUS N/A
  • LUMN N/A
  • P/E Ratio
  • MRUS N/A
  • LUMN N/A
  • Revenue Growth
  • MRUS 59.77
  • LUMN N/A
  • 52 Week Low
  • MRUS $33.19
  • LUMN $3.01
  • 52 Week High
  • MRUS $95.30
  • LUMN $11.32
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 79.21
  • LUMN 85.41
  • Support Level
  • MRUS $94.59
  • LUMN $6.76
  • Resistance Level
  • MRUS $95.06
  • LUMN $7.31
  • Average True Range (ATR)
  • MRUS 0.36
  • LUMN 0.57
  • MACD
  • MRUS -1.00
  • LUMN 0.35
  • Stochastic Oscillator
  • MRUS 47.87
  • LUMN 93.52

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About LUMN Lumen Technologies Inc.

With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 have shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen has announced the sale of its consumer fiber network, but will maintain and harvest its legacy consumer copper network.

Share on Social Networks: